135 related articles for article (PubMed ID: 32950495)
21. Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease.
Zhao Y; Shen A; Guo F; Song Y; Jing N; Ding X; Pan M; Zhang H; Wang J; Wu L; Ma X; Feng L; Qin G
Front Endocrinol (Lausanne); 2020; 11():590. PubMed ID: 32982978
[TBL] [Abstract][Full Text] [Related]
22. Dual approach for the colorimetric determination of unamplified microRNAs by using citrate capped gold nanoparticles.
Nossier AI; Abdelzaher H; Matboli M; Eissa S
Mikrochim Acta; 2018 Mar; 185(4):236. PubMed ID: 29594755
[TBL] [Abstract][Full Text] [Related]
23. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.
Beltrami C; Simpson K; Jesky M; Wonnacott A; Carrington C; Holmans P; Newbury L; Jenkins R; Ashdown T; Dayan C; Satchell S; Corish P; Cockwell P; Fraser D; Bowen T
Am J Pathol; 2018 Sep; 188(9):1982-1992. PubMed ID: 29981742
[TBL] [Abstract][Full Text] [Related]
24. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
Abdel-Tawab MS; Mohamed MG; Doudar NA; Rateb EE; Reyad HR; Elazeem NAA
Mol Biol Rep; 2023 Dec; 50(12):9793-9803. PubMed ID: 37831346
[TBL] [Abstract][Full Text] [Related]
25. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.
Chen J; Zhang WW; Chen KH; Lin LR; Dai HZ; Li KL; Zhang JG; Zheng LQ; Fu BQ; He YN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F273-F281. PubMed ID: 28356293
[TBL] [Abstract][Full Text] [Related]
26. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
27. Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension.
Perez-Hernandez J; Olivares D; Forner MJ; Ortega A; Solaz E; Martinez F; Chaves FJ; Redon J; Cortes R
J Transl Med; 2018 Aug; 16(1):228. PubMed ID: 30107841
[TBL] [Abstract][Full Text] [Related]
28. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
30. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.
Newbury LJ; Wonnacott A; Simpson K; Bowen T; Fraser D
Methods Mol Biol; 2020; 2067():277-285. PubMed ID: 31701457
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of urinary transferrin for early diagnosis of diabetic nephropathy.
Li B; Wang J; Ye W
Lab Med; 2024 Jul; 55(4):413-419. PubMed ID: 38335130
[TBL] [Abstract][Full Text] [Related]
33. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.
Kim H; Bae YU; Jeon JS; Noh H; Park HK; Byun DW; Han DC; Ryu S; Kwon SH
J Transl Med; 2019 Jul; 17(1):236. PubMed ID: 31331349
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
35. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
[TBL] [Abstract][Full Text] [Related]
36. Urinary miR-3137 and miR-4270 as potential biomarkers for diabetic kidney disease.
Li X; Xu R; Liu X; Xu L; Xue M; Cheng Y; Li T; Yu X; Wang Y; Li C; Sun B; Chen L
J Clin Lab Anal; 2020 Dec; 34(12):e23549. PubMed ID: 32869917
[TBL] [Abstract][Full Text] [Related]
37. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Ching-Ha KB; Ka-Bik L; Mac-Moune LF; Cheung-Lung CP; Gang W; Kai-Ming C; Kam-Tao LP
Dis Markers; 2012; 33(3):137-44. PubMed ID: 22960330
[TBL] [Abstract][Full Text] [Related]
38. Association of Complement and Inflammatory Biomarkers with Diabetic Nephropathy.
Huang H; Li D; Huang X; Wang Y; Wang S; Wang X; Yang X
Ann Clin Lab Sci; 2019 Sep; 49(4):488-495. PubMed ID: 31471338
[TBL] [Abstract][Full Text] [Related]
39. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
40. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
